AccessMyLibrary provides FREE access to over 30 million articles from top publications available through your library.
Create a link to this page
Copy and paste this link tag into your Web page or blog:
2002 JAN 9 - (NewsRx.com & NewsRx.net) -- High demand for a new vaccine against childhood pneumonia, meningitis, and ear infections has led to a shortage around the country.
The shortage of Prevnar should ease by the end of March 2002 said its maker, Wyeth-Ayerst Laboratories. Meanwhile, doctors are directing the supplies they do have to children who run the highest risk of infection, such as those with sickle cell anemia, the AIDS virus or other diseases that undermine the immune system.
"We've got it. We just don't have a lot of it," said Dr. Joe Hagan, a pediatrician in South Burlington, Vermont.
Prevnar fights the bacterium Streptococcus pneumoniae, the leading cause of pneumonia, meningitis and millions of ear infections every year in children. According to the U.S. Food and Drug Administration, U.S. children under age five suffer 16,000 pneumococcal blood infections and 1,400 pneumococcal meningitis cases every year. And until Prevnar, there has been no way to prevent them. In up to half the cases of meningitis, children suffer brain ...